WHO approves India’s ‘Kovovax’.

The World Health Organization (WHO) added Kovovax, an anti-Covid vaccine manufactured by the Serum Institute of India (SII) under license from US pharmaceutical company Novavax, to its emergency use list. In this way the number of vaccines approved by the global health body has increased. SII Chief Executive Officer (CEO) Aadar Poonawalla described the WHO’s decision as ‘another milestone’ in the fight against COVID-19.

The World Health Organization said in a tweet on Friday, ‘WHO has added Kovovax to its emergency use list. This has increased the number of WHO validated vaccines against Kovid-19. This vaccine is manufactured by Serum Institute of India under license from Novavax. According to the WHO, Covovax was assessed on the basis of its emergency use inventory process based on a review of data on quality, safety and efficacy, risk management plan and vaccine manufacturing site inspections by the Drug Controller General of India (DCGI).

Source: https://hindustannewshub.com


No comments:

Post a Comment




Popular Posts

Blog Archive

Recent Posts